abstract |
In the present invention, novel PRMT5 inhibitors and methods for their preparation are described. Pharmaceutical compositions comprising such PRMT5 inhibitors and methods of their use for the treatment of cancer, infectious diseases, and other PRMT5 related disorders are also described. |